Targeting c-Rel in this manner might demonstrate an anti-tumor effect both on the cancer cell and immune system levels to convert an immunologically “cold” tumor into a “hot” one, thereby enhancing immunotherapy efficiency [118]. The gene discussed is REL; the disease is neoplasm.